Mary T. Szela, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 2,090 shares at $56.00 ($117K) on 2009-02-03, disclosed to the SEC on 2009-02-05.
Scheduled sale ($117k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TLSI | SELL | 2026-03-20 | $79K | — | Filing → |
| TLSI | BUY | 2026-02-23 | $125K | — | Filing → |
| TLSI | BUY | 2025-01-31 | $52K | — | Filing → |